Literature DB >> 17558824

Interest in gradual cessation.

John R Hughes1, Peter W Callas, Erica N Peters.   

Abstract

Prior surveys have not determined smokers' interest in gradual cessation. In Study 1A, we advertised in six U.S. east coast newspapers for "smokers who plan to quit smoking" to participate in a nontreatment study. Among the 461 respondents, 66% planned to reduce and then stop smoking, 13% planned to stop abruptly, and 21% reported they planned to reduce but not quit. In Study 1B, we ran a similar ad but asked for "smokers who plan to reduce their smoking." Among the 263 respondents, 57% planned to reduce and then stop smoking and 33% planned to reduce but not stop smoking. In Study 2, we asked 125 smokers to rate their interest in quitting smoking (on a 1-10 scale) given two scenarios. When nicotine replacement therapy (NRT) was not mentioned, interest in gradual cessation was high and was higher than interest in abrupt cessation (6.9 and 4.7, respectively, p<.0001). When NRT was assumed to be available for gradual or abrupt cessation, interest in gradual cessation remained high (7.1) and was similar to that for abrupt cessation (7.0). In both scenarios, over three-fourths of smokers were at least as interested in gradual cessation as they were in abrupt cessation.

Entities:  

Mesh:

Year:  2007        PMID: 17558824     DOI: 10.1080/14622200701365293

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  13 in total

1.  A randomized, controlled trial of NRT-aided gradual vs. abrupt cessation in smokers actively trying to quit.

Authors:  John R Hughes; Laura J Solomon; Amy E Livingston; Peter W Callas; Erica N Peters
Journal:  Drug Alcohol Depend       Date:  2010-05-26       Impact factor: 4.492

2.  A pilot study to assess smokeless tobacco use reduction with varenicline.

Authors:  Jon O Ebbert; Ivana T Croghan; Frederick North; Darrell R Schroeder
Journal:  Nicotine Tob Res       Date:  2010-08-19       Impact factor: 4.244

Review 3.  WITHDRAWN: Reduction versus abrupt cessation in smokers who want to quit.

Authors:  Nicola Lindson; Paul Aveyard; John R Hughes
Journal:  Cochrane Database Syst Rev       Date:  2019-10-01

4.  R-modafinil attenuates nicotine-taking and nicotine-seeking behavior in alcohol-preferring rats.

Authors:  Xiao-Fei Wang; Guo-Hua Bi; Yi He; Hong-Ju Yang; Jun-Tao Gao; Oluyomi M Okunola-Bakare; Rachel D Slack; Eliot L Gardner; Zheng-Xiong Xi; Amy Hauck Newman
Journal:  Neuropsychopharmacology       Date:  2015-01-23       Impact factor: 7.853

5.  Smokers' use of nicotine replacement therapy for reasons other than stopping smoking: findings from the ITC Four Country Survey.

Authors:  David Hammond; Jessica L Reid; Pete Driezen; K Michael Cummings; Ron Borland; Geoffrey T Fong; Ann McNeill
Journal:  Addiction       Date:  2008-10       Impact factor: 6.526

6.  The global research neglect of unassisted smoking cessation: causes and consequences.

Authors:  Simon Chapman; Ross MacKenzie
Journal:  PLoS Med       Date:  2010-02-09       Impact factor: 11.069

7.  Integrating a Behavioural Sleep Intervention into Smoking Cessation Treatment for Smokers with Insomnia: A Randomised Pilot Study.

Authors:  Lisa M Fucito; Nancy S Redeker; Samuel A Ball; Benjamin A Toll; Jolomi T Ikomi; Kathleen M Carroll
Journal:  J Smok Cessat       Date:  2014-06

8.  A test of motivational plus nicotine replacement interventions for HIV positive smokers.

Authors:  Karen S Ingersoll; Karen L Cropsey; Carolyn J Heckman
Journal:  AIDS Behav       Date:  2007-12-08

9.  An ecological momentary assessment analysis of prequit markers for smoking-cessation failure.

Authors:  Vivian M Yeh; Danielle E McCarthy; Timothy B Baker
Journal:  Exp Clin Psychopharmacol       Date:  2012-08-27       Impact factor: 3.157

10.  Rapid reduction versus abrupt quitting for smokers who want to stop soon: a randomised controlled non-inferiority trial.

Authors:  Nicola Lindson; Paul Aveyard; Jackie T Ingram; Jennie Inglis; Jane Beach; Robert West; Susan Michie
Journal:  Trials       Date:  2009-08-14       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.